Searchable abstracts of presentations at key conferences in endocrinology

ea0063p877 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Accuracy of adrenal imaging studies in predicting histological tumor dimension following adrenalectomy

Alexandraki Krystallenia , Aggeli Chrysanthi , Antonopoulou Ioanna , Parianos Christos , Ntokos George , Pateas Konstantinos , Kaltsas Gregory , Zografos Georgios

Introduction: Although computed tomography (CT) is the best mean to identify adrenal neoplasms there is still controversy of the concordance of the estimated radiological and histological size of the lesion. Since the size of adrenal tumours is a major criterion for surgical excision, we investigated whether recent and more sophisticated imaging techniques, can more accurately predict tumor’s size.Methods: We have retrospectively analyzed a series o...

ea0070oc6.3 | Hot Topics (including COVID-19 | ECE2020

Expression of estrogen-related receptors and epidermal growth factor receptor in normal adrenal cortex and adrenocortical tumors: A possible role of GPR30 and EGFR in adrenocortical malignancy

Parianos Christos , Kyriakopoulos Georgios , Nasiri-Ansari Narjes , Karapanagioti Angeliki , Angelousi Anna , Aggeli Chrysanthi , Zografos Giorgos , Choreftaki Theodosia , Kounadi Theodora , Randeva Harpal , Kaltsas Gregory , Papavassiliou Athanasios G , Kassi Evanthia

Introduction: The majority of adrenal neoplasms are benign while adrenocortical carcinomas (ACC) are rare with poor prognosis. Previous studies indicated that estrogens play important role in the etiology and progression of adrenocortical tumors. Estrogens exert genomic activities trough the estrogen-receptor (ER) subtypes α and β, while the non-genomic effects are mediated by membrane-bound-G-protein-coupled-ER-30 (GPR30). Although estrogens induce cancer cell ...

ea0070aep98 | Adrenal and Cardiovascular Endocrinology | ECE2020

Expression ofestrogen-related receptors andepidermal growth factor receptorin normal adrenal cortex and adrenocortical tumors: A possible role of GPR30 and EGFR in adrenocortical malignancy

Parianos Christos , Kyriakopoulos Georgios , Nasiri-Ansari Narjes , Karapanagioti Angeliki , Angelousi Anna , Aggeli Chrysanthi , Zografos Giorgos , Choreftaki Theodosia , Kounadi Theodora , Randeva Harpal , Kaltsas Gregory , Papavassiliou Athanasios G , Kassi Evanthia

Introduction: The majority of adrenal neoplasms are benign while adrenocortical carcinomas (ACC) are rare with poor prognosis. Previous studies indicated that estrogens play important role in the etiology and progression of adrenocortical tumors. Estrogens exert genomic activities trough the estrogen-receptor (ER) subtypes α and β, while the non-genomic effects are mediated by membrane-bound-G-protein-coupled-ER-30 (GPR30). Although estrogens induce cancer cell ...

ea0073aep63 | Adrenal and Cardiovascular Endocrinology | ECE2021

Prognostic factors in Adrenocortical Carcinoma: A single institution case-series

Parianos Christos , Kyriakopoulos Georgios , Kostakis Ioannis D. , Nasiri-Ansari Narjes , Aggeli Chrysanthi , Angelousi Anna , Choreftaki Theodosia , Papavassiliou Athanasios G. , Kaltsas Gregory , Zografos Giorgos , Kassi Evanthia

BackgroundAdrenocortical carcinoma (ACC) is a rare but very aggressive endocrine malignancy with poor survival. Histopathology is important for diagnosis, while in some cases immunohistochemical markers and gene profiling of the resected tumor may be superior to current staging systems to determine prognosis.AimHerein, we aimed to present the 20year experience at a tertiary Hospital in patients with ACCs and ...